The human plasma proteome: history, character, and diagnostic prospects - PubMed (original) (raw)
Review
The human plasma proteome: history, character, and diagnostic prospects
N Leigh Anderson et al. Mol Cell Proteomics. 2002 Nov.
Free article
Erratum in
- Mol Cell Proteomics. 2003 Jan;2(1):50
Abstract
The human plasma proteome holds the promise of a revolution in disease diagnosis and therapeutic monitoring provided that major challenges in proteomics and related disciplines can be addressed. Plasma is not only the primary clinical specimen but also represents the largest and deepest version of the human proteome present in any sample: in addition to the classical "plasma proteins," it contains all tissue proteins (as leakage markers) plus very numerous distinct immunoglobulin sequences, and it has an extraordinary dynamic range in that more than 10 orders of magnitude in concentration separate albumin and the rarest proteins now measured clinically. Although the restricted dynamic range of conventional proteomic technology (two-dimensional gels and mass spectrometry) has limited its contribution to the list of 289 proteins (tabulated here) that have been reported in plasma to date, very recent advances in multidimensional survey techniques promise at least double this number in the near future. Abundant scientific evidence, from proteomics and other disciplines, suggests that among these are proteins whose abundances and structures change in ways indicative of many, if not most, human diseases. Nevertheless, only a handful of proteins are currently used in routine clinical diagnosis, and the rate of introduction of new protein tests approved by the United States Food and Drug Administration (FDA) has paradoxically declined over the last decade to less than one new protein diagnostic marker per year. We speculate on the reasons behind this large discrepancy between the expectations arising from proteomics and the realities of clinical diagnostics and suggest approaches by which protein-disease associations may be more effectively translated into diagnostic tools in the future.
Similar articles
- Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.
Pieper R, Su Q, Gatlin CL, Huang ST, Anderson NL, Steiner S. Pieper R, et al. Proteomics. 2003 Apr;3(4):422-32. doi: 10.1002/pmic.200390057. Proteomics. 2003. PMID: 12687610 - The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins.
Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, Zhao M, Huang ST, Zhou J, Wang F, Esquer-Blasco R, Anderson NL, Taylor J, Steiner S. Pieper R, et al. Proteomics. 2003 Jul;3(7):1345-64. doi: 10.1002/pmic.200300449. Proteomics. 2003. PMID: 12872236 - Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis.
Linke T, Doraiswamy S, Harrison EH. Linke T, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 15;849(1-2):273-81. doi: 10.1016/j.jchromb.2006.11.051. Epub 2006 Dec 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17188586 - Plasma proteome analysis: 2D gels and chips.
Herosimczyk A, Dejeans N, Sayd T, Ozgo M, Skrzypczak WF, Mazur A. Herosimczyk A, et al. J Physiol Pharmacol. 2006 Nov;57 Suppl 7:81-93. J Physiol Pharmacol. 2006. PMID: 17228097 Review. - Plasma-derived microparticles for biomarker discovery.
Smalley DM, Ley K. Smalley DM, et al. Clin Lab. 2008;54(3-4):67-79. Clin Lab. 2008. PMID: 18630736 Review.
Cited by
- Statistical methods for quantitative mass spectrometry proteomic experiments with labeling.
Oberg AL, Mahoney DW. Oberg AL, et al. BMC Bioinformatics. 2012;13 Suppl 16(Suppl 16):S7. doi: 10.1186/1471-2105-13-S16-S7. Epub 2012 Nov 5. BMC Bioinformatics. 2012. PMID: 23176383 Free PMC article. Review. - Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics.
Mani DR, Abbatiello SE, Carr SA. Mani DR, et al. BMC Bioinformatics. 2012;13 Suppl 16(Suppl 16):S9. doi: 10.1186/1471-2105-13-S16-S9. Epub 2012 Nov 5. BMC Bioinformatics. 2012. PMID: 23176545 Free PMC article. - An ex vivo approach to botanical-drug interactions: a proof of concept study.
Wang X, Zhu HJ, Munoz J, Gurley BJ, Markowitz JS. Wang X, et al. J Ethnopharmacol. 2015 Apr 2;163:149-56. doi: 10.1016/j.jep.2015.01.021. Epub 2015 Jan 24. J Ethnopharmacol. 2015. PMID: 25623616 Free PMC article. - Development of gel-filter method for high enrichment of low-molecular weight proteins from serum.
Chen L, Zhai L, Li Y, Li N, Zhang C, Ping L, Chang L, Wu J, Li X, Shi D, Xu P. Chen L, et al. PLoS One. 2015 Feb 27;10(2):e0115862. doi: 10.1371/journal.pone.0115862. eCollection 2015. PLoS One. 2015. PMID: 25723528 Free PMC article. - Integrated acoustic immunoaffinity-capture (IAI) platform for detection of PSA from whole blood samples.
Tajudin AA, Petersson K, Lenshof A, Swärd-Nilsson AM, Aberg L, Marko-Varga G, Malm J, Lilja H, Laurell T. Tajudin AA, et al. Lab Chip. 2013 May 7;13(9):1790-6. doi: 10.1039/c3lc41269e. Lab Chip. 2013. PMID: 23515524 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources